FDA User Fee Rates Will Increase 17% For Fiscal Year 2005
This article was originally published in The Pink Sheet Daily
Executive Summary
Applications including clinical data will cost $672,000. Applications without clinical data and supplemental applications with clinical data will cost $336,000.
You may also be interested in...
User Fee Formula Does Not Account For Greater Number Of Industry-Requested Meetings, FDA Says
An agency white paper reports that increasing drug development costs and thinning pipelines are prompting more companies to seek formal advice from FDA in the IND phase, increasing the agency’s workload.
User Fee Formula Does Not Account For Greater Number Of Industry-Requested Meetings, FDA Says
An agency white paper reports that increasing drug development costs and thinning pipelines are prompting more companies to seek formal advice from FDA in the IND phase, increasing the agency’s workload.
FDA Received More User-Fee Paying Applications In FY 2004 Than Expected
With a “greater than anticipated” number of fee-paying applications received by FDA, the agency collected $5 mil. more than projected at the beginning of the year, the FY 2004 PDUFA Financial Report states.